Xiang-Min Yang
Overview
Explore the profile of Xiang-Min Yang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
1520
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang J, Song C, Wang M, Zhang G, Wang B, Chen X, et al.
J Pharm Anal
. 2023 Nov;
13(10):1135-1152.
PMID: 38024852
Morphine is a frequently used analgesic that activates the mu-opioid receptor (MOR), which has prominent side effects of tolerance. Although the inefficiency of morphine in inducing the endocytosis of MOR...
2.
Zhai Y, Chen L, Zhao Q, Zheng Z, Chen Z, Bian H, et al.
Science
. 2023 Mar;
379(6637):eabg2482.
PMID: 36927018
Autoimmune diseases such as ankylosing spondylitis (AS) can be driven by emerging neoantigens that disrupt immune tolerance. Here, we developed a workflow to profile posttranslational modifications involved in neoantigen formation....
3.
Zhang J, Song C, Dai J, Li L, Yang X, Chen Z
MedComm (2020)
. 2022 Jul;
3(3):e148.
PMID: 35774845
Opioid abuse and addiction have become a global pandemic, posing tremendous health and social burdens. The rewarding effects and the occurrence of withdrawal symptoms are the two mainstays of opioid...
4.
Dai J, Zhang X, Zhang J, Yang W, Yang X, Bian H, et al.
MedComm (2020)
. 2022 May;
3(2):e132.
PMID: 35548710
Systemic inflammatory response syndrome (SIRS) is characterized by dysregulated cytokine release, immune responses and is associated with organ dysfunction. IL-6R blockade indicates promising therapeutic effects in cytokine release storm but...
5.
Zheng M, Li Y, Liu Z, Zhang X, Zhou Y, Jiang J, et al.
Front Immunol
. 2022 Jan;
12:731329.
PMID: 35069521
Recently, immunotherapy targeting tumor-infiltrating lymphocytes (TILs) has emerged as a critical and promising treatment in several types of cancer. However, not all cancer types have been tested in immunotherapeutic trials,...
6.
Cui H, Wang S, Song F, Cheng X, Nan G, Zhao Y, et al.
Signal Transduct Target Ther
. 2021 Jul;
6(1):268.
PMID: 34262017
Major gaps in understanding the molecular mechanisms of colorectal cancer (CRC) progression and intestinal mucosal repair have hampered therapeutic development for gastrointestinal disorders. Trefoil factor 3 (TFF3) has been reported...
7.
Zhang J, Song C, Dai J, Zhang X, Lin P, Li L, et al.
Am J Transl Res
. 2021 Jun;
13(5):3967-3986.
PMID: 34149993
Hepatocellular carcinoma (HCC) is the leading cause of cancer-related deaths. Previous studies have suggested that mu-opioid receptor (MOR), a member of the opioid receptor family, is involved in the pathogenesis...
8.
Bian H, Zheng Z, Wei D, Wen A, Zhang Z, Lian J, et al.
Signal Transduct Target Ther
. 2021 May;
6(1):194.
PMID: 34001849
Recent evidence suggests that CD147 serves as a novel receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Blocking CD147 via anti-CD147 antibody could suppress the in vitro SARS-CoV-2...
9.
Dai J, Guo W, Tan Y, Niu K, Zhang J, Liu C, et al.
J Cell Mol Med
. 2021 May;
25(12):5782-5798.
PMID: 33982381
Sepsis is a life-threatening organ dysfunction syndrome, and liver is a susceptible target organ in sepsis, because the activation of inflammatory pathways contributes to septic liver injury. Oxidative stress has...
10.
Wang K, Chen W, Zhang Z, Deng Y, Lian J, Du P, et al.
Signal Transduct Target Ther
. 2020 Dec;
5(1):283.
PMID: 33277466
In face of the everlasting battle toward COVID-19 and the rapid evolution of SARS-CoV-2, no specific and effective drugs for treating this disease have been reported until today. Angiotensin-converting enzyme...